VSTM FY 2016 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$670,000

Operating Income

-$37M

Net Income

-$36M

EPS (Diluted)

$-11.82

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$84M

Total Liabilities

$11M

Stockholders' Equity

$72M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$670,000	-$754,000	+11.1%
Operating Income	-$37M	-$58M	+36.4%
Net Income	-$36M	-$58M	+37.0%